Attendees at the 2020 BCLA UK Virtual Conference and Exhibition had the opportunity to learn more about some of the latest research in eye health as part of the meeting’s scientific programme. Krupa Patel, Head of Professional Services UK & Ireland said, “As Partner-level sponsors of the BCLA, we were delighted to support this virtual event. At CooperVision, we recognise the ongoing challenges brought by the COVID-19 pandemic and were pleased to present new research, insights and practice tools to support the business recovery and future growth of eye care professionals.”
Among the research posters were several CooperVision-affiliated clinical papers and research posters covering a range of topics, including myopia management, consumer insights during COVID-19 times, SiH 1 day contact lens materials and more “At a time when eye care professionals (ECPs) are being inundated by new products and marketing claims, we want to ensure that sound science continues to be central to clinical decisions,” said Anna Sulley, BSc (Hons), MCOptom, FAAO, FBCLA, Director, Global Medical Affairs for CooperVision. “Our scientific presentations focus on inventive products currently available, novel concepts that may give rise to future developments, and attitudes and behaviours among ECPs and consumers that have industry-wide impacts.” CooperVision and CooperVision Specialty Eye Care shared research including analysis of opportunities to increase parental and ECP understanding of the disease, proven myopia management outcomes with the MiSight® 1 day contact lens, and myopia management advancements using orthokeratology. CooperVision also used the conference to highlight its Brilliant Futures™ myopia management programme, introducing a new standard of care for children with myopia by providing practice team, child and parent support.